D. G. Sherman Et Al. , "The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venousthromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison," LANCET , vol.369, no.9570, pp.1347-1355, 2007
Sherman, D. G. Et Al. 2007. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venousthromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. LANCET , vol.369, no.9570 , 1347-1355.
Sherman, D. G., Albers, G. W., Bladin, C., Fieschi, C., Gabbai, A. A., Kase, C. S., ... O'Riordan, W.(2007). The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venousthromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. LANCET , vol.369, no.9570, 1347-1355.
Sherman, David Et Al. "The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venousthromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison," LANCET , vol.369, no.9570, 1347-1355, 2007
Sherman, David G. Et Al. "The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venousthromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison." LANCET , vol.369, no.9570, pp.1347-1355, 2007
Sherman, D. G. Et Al. (2007) . "The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venousthromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison." LANCET , vol.369, no.9570, pp.1347-1355.
@article{article, author={David G. Sherman Et Al. }, title={The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venousthromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison}, journal={LANCET}, year=2007, pages={1347-1355} }